Ibandronic acid Osteoviva® contains the active substance ibandronic acid.
Ibandronic acid Osteoviva® belongs to a group of medicines called bisphosphonates. Ibandronic acid Osteoviva® can counteract bone loss by stopping further bone loss and increasing bone mass in most women who take it. Ibandronic acid Osteoviva® can help reduce the risk of bone fractures.
Ibandronic acid Osteoviva® is used to treat osteoporosis in postmenopausal women at increased risk of fractures.
Strength | Pack size | Dosage form | Appearance |
3 mg | 1 (à 3 ml) | Pre-filled syringes |
![]() |